Anjana Rao
Tanaz Sharifnia
Tanaz Sharifnia is a research scientist and investigator in the Chemical Biology and Therapeutics Science Program at the Broad Institute of Harvard and MIT. Her research interests include applying systematic functional genomic and small-molecule-based approaches to discover and target cancer vulnerabilities. Working in close partnership with other scientists, clinicians, a medical research foundation, and patients, she seeks to translate basic research insights into new therapies for patients with intractable cancers. Dr. Sharifnia received her Ph.D. in the field of cancer genomics from Harvard University.
Melinda Day
Jun Qin
Lindsay Pino
I’m a postdoctoral researcher with over a decade of experience in developing mass spectrometry proteomics methods for studying human disease. I’ve trained at the Broad Institute, the University of Washington, and most recently the University of Pennsylvania. My focus is on developing techniques for quantitative proteomics and in particular I’m interested in the challenges associated with scaling-up quantitative proteomics experiments. Lately, I’ve been working on expanding these techniques to target dynamic systems including protein turnover, epigenetics, and protein interactions.
Outside of research, I am a runner, dog owner, and hiker. Although I completed my first full marathon in 2015, I mostly stick to 5-10k’s with my shelter dog now. I’m most at home in the mountains, especially backpacking. My latest hobby is perfecting my macaron recipe, thanks to the Great British Bake-Off.
Mario Iurlaro
I was born in the seaside city of Taranto, in the south of Italy. I studied Molecular Biotechnologies in Bologna, with 1 year spent at the University of Oxford for my MSc internship. Tired of good weather and great food, for my PhD I moved to Cambridge, UK, where I investigated DNA methylation dynamics in early mammalian development and the biological function of novel DNA modifications. I am currently studying the mechanisms regulating the interaction between chromatin modifications, nucleosome remodelers and transcription factor binding. I enjoy obscure movies, travelling and the NBA playoffs.
David Weinstock
Dr. David Weinstock is the Lavine Family Professor at Dana-Farber Cancer Institute and a Professor of Medicine and Pediatrics Harvard Medical School. He completed fellowship training in Medical Oncology and Infectious Diseases at Memorial Sloan-Kettering Cancer Center. He joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital in 2008, where he is a medical oncologist and directs the Weinstock Laboratory, a translational research program focused on novel therapeutics for lymphoid malignancies. He developed the Public Repository of Xenografts (http://www.PRoXe.org), which shares >800 patient-derived xenograft models around the world. He leads the Leukemia Program for the Dana-Farber/Harvard Cancer Center.